Duloxetine EP Impurity D | CAS 90-15-3 - Request Quote
Duloxetine EP Impurity D
| SZ CAT No: | SZ-D001005 |
| CAS No | 90-15-3 |
| Mol.F. | C10H8O |
| Mol.Wt. | 144.2 |
| Inv. Status | In Stock |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Duloxetine EP Impurity D is chemically Naphthalen-1-ol (as per EP & USP). It is also known as α-Napthol (USP). Duloxetine EP Impurity D is supplied with detailed characterization data compliant with regulatory guideline. Duloxetine EP Impurity D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Duloxetine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 90-15-3
Purchase 90-15-3
Order 90-15-3
Enquire 90-15-3
price of 90-15-3
90-15-3 Supplier
90-15-3 Manufacturer
90-15-3 Exporter
buy high quality Duloxetine EP Impurity D
Purchase Duloxetine EP Impurity D
Duloxetine EP Impurity D suppliers
Duloxetine EP Impurity D manufacturers
Duloxetine EP Impurity D price
Order Duloxetine EP Impurity D
Enquire Duloxetine EP Impurity D
Duloxetine EP Impurity D cost
Duloxetine EP Impurity D Supplier
Duloxetine EP Impurity D Distributor
Duloxetine EP Impurity D for Method Validation
Duloxetine Reference Standard
Duloxetine EP Impurity D for ANDA Filing
Duloxetine EP Impurity D for Forced Degradation Studies
Duloxetine EP Impurity D Identification Standards
Duloxetine EP Impurity D for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


